Literature DB >> 21115033

SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus.

Kelli R Rodvelt1, Susan Z Lever, John R Lever, Lucas R Blount, Kuo-Hsien Fan, Dennis K Miller.   

Abstract

Cocaine exhibits preferential (~15-fold) affinity for σ₁ over σ₂ sigma receptors, and previous research has shown an interaction of σ₁ receptor-selective ligands and cocaine's behavioral effects. The present study investigated the effect of the putative sigma receptor agonist SA 4503 (1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride) on cocaine's locomotor stimulatory and discriminative stimulus properties. At doses without intrinsic activity, SA 4503 dose-dependently attenuated cocaine-induced hyperactivity in mice. This inhibition was overcome by increasing the cocaine dose. In rats trained to use cocaine as a discriminative stimulus in a drug discrimination task, doses of SA 4503 that did not substitute for the cocaine stimulus did not alter the cocaine substitution curve. However, SA 4503 potentiated the effect of methamphetamine to substitute for the cocaine stimulus. These data support a role for sigma receptors in the locomotor-activating properties of cocaine and, importantly, indicate a role for these receptors in the discriminative stimulus effects of methamphetamine. The data also suggest sigma receptors mediate the activity of different dopamine pathways responsible for the behavioral effects of psychostimulants.
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115033      PMCID: PMC3023454          DOI: 10.1016/j.pbb.2010.11.016

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  21 in total

1.  Effect of sigma ligands on the cocaine-induced convulsions in mice.

Authors:  G Skuza
Journal:  Pol J Pharmacol       Date:  1999 Nov-Dec

2.  The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine.

Authors:  Kelli R Rodvelt; Clark E Oelrichs; Lucas R Blount; Kuo-Hsien Fan; Susan Z Lever; John R Lever; Dennis K Miller
Journal:  Drug Alcohol Depend       Date:  2011-02-01       Impact factor: 4.492

Review 3.  Sigma receptors: biology and function.

Authors:  J M Walker; W D Bowen; F O Walker; R R Matsumoto; B De Costa; K C Rice
Journal:  Pharmacol Rev       Date:  1990-12       Impact factor: 25.468

4.  A potential antidepressant activity of SA4503, a selective sigma 1 receptor agonist.

Authors:  G Skuza; Z Rogóz
Journal:  Behav Pharmacol       Date:  2002-11       Impact factor: 2.293

5.  Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons.

Authors:  G F Steinfels; S W Tam; L Cook
Journal:  Neuropsychopharmacology       Date:  1989-09       Impact factor: 7.853

6.  The selective sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats.

Authors:  B Horan; E L Gardner; S L Dewey; J D Brodie; C R Ashby
Journal:  Eur J Pharmacol       Date:  2001-08-24       Impact factor: 4.432

7.  Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade.

Authors:  Pascal Romieu; Vân Ly Phan; Rémi Martin-Fardon; Tangui Maurice
Journal:  Neuropsychopharmacology       Date:  2002-04       Impact factor: 7.853

8.  Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides.

Authors:  Rae R Matsumoto; Kari A McCracken; Buddy Pouw; Ying Zhang; Wayne D Bowen
Journal:  Neuropharmacology       Date:  2002-06       Impact factor: 5.250

Review 9.  When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor.

Authors:  Tsung-Ping Su; Teruo Hayashi; D Bruce Vaupel
Journal:  Sci Signal       Date:  2009-03-10       Impact factor: 8.192

10.  Reinforcing effects of sigma-receptor agonists in rats trained to self-administer cocaine.

Authors:  Takato Hiranita; Paul L Soto; Gianluigi Tanda; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2009-11-05       Impact factor: 4.030

View more
  15 in total

Review 1.  The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

Authors:  Danielle O Sambo; Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Pharmacol Ther       Date:  2018-01-31       Impact factor: 12.310

2.  Lack of cocaine-like discriminative-stimulus effects of σ-receptor agonists in rats.

Authors:  Takato Hiranita; Paul L Soto; Gianluigi Tanda; Jonathan L Katz
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

3.  Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters.

Authors:  Rong Xu; Sarah A Lord; Ryan M Peterson; Emily A Fergason-Cantrell; John R Lever; Susan Z Lever
Journal:  Bioorg Med Chem       Date:  2014-11-11       Impact factor: 3.641

Review 4.  Tactics for preclinical validation of receptor-binding radiotracers.

Authors:  Susan Z Lever; Kuo-Hsien Fan; John R Lever
Journal:  Nucl Med Biol       Date:  2016-09-03       Impact factor: 2.408

5.  Cocaine occupancy of sigma1 receptors and dopamine transporters in mice.

Authors:  John R Lever; Emily A Fergason-Cantrell; Lisa D Watkinson; Terry L Carmack; Sarah A Lord; Rong Xu; Dennis K Miller; Susan Z Lever
Journal:  Synapse       Date:  2015-12-24       Impact factor: 2.562

6.  In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.

Authors:  William E Fantegrossi; Brenda M Gannon; Sarah M Zimmerman; Kenner C Rice
Journal:  Neuropsychopharmacology       Date:  2012-11-08       Impact factor: 7.853

7.  Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418.

Authors:  John R Lever; Dennis K Miller; Emily A Fergason-Cantrell; Caroline L Green; Lisa D Watkinson; Terry L Carmack; Susan Z Lever
Journal:  J Pharmacol Exp Ther       Date:  2014-08-06       Impact factor: 4.030

8.  Synthesis and σ1 Receptor Binding of Halogenated N,N'-Diphenethylethylenediamines.

Authors:  Jonathan M Fitzsimmons; John R Lever; Susan Z Lever
Journal:  Med Chem (Los Angeles)       Date:  2011-12-25

9.  The sigma receptor ligand N-phenylpropyl-N'-(4-methoxyphenethyl)3piperazine (YZ-067) enhances the cocaine conditioned-rewarding properties while inhibiting the development of sensitization of cocaine in mice.

Authors:  Melissa A Tapia; Andrew S Sage; Emma I Fullerton; Jessica M Judd; Paige C Hildebrant; Matthew J Will; Susan Z Lever; John R Lever; Dennis K Miller
Journal:  Psychopharmacology (Berl)       Date:  2019-12-10       Impact factor: 4.530

10.  Sigma-1 receptor ligand PD144418 and sigma-2 receptor ligand YUN-252 attenuate the stimulant effects of methamphetamine in mice.

Authors:  Melissa A Tapia; John R Lever; Susan Z Lever; Matthew J Will; Eric S Park; Dennis K Miller
Journal:  Psychopharmacology (Berl)       Date:  2019-05-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.